Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI).
McCormack M, Paczkowski R, Gronroos NN, Noorduyn SG, Lee L, Veeranki P, Johnson MG, Igboekwe E, Kahle-Wrobleski K, Panettieri R. McCormack M, et al. Among authors: paczkowski r. Adv Ther. 2024 Mar;41(3):1245-1261. doi: 10.1007/s12325-023-02776-8. Epub 2024 Feb 4. Adv Ther. 2024. PMID: 38310193 Free PMC article.
Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI).
Baptist AP, Germain G, Klimek J, Laliberté F, Schell RC, Forero-Schwanhaeuser S, Moore A, Noorduyn SG, Paczkowski R. Baptist AP, et al. Among authors: paczkowski r. Adv Ther. 2024 Dec 23. doi: 10.1007/s12325-024-03083-6. Online ahead of print. Adv Ther. 2024. PMID: 39714547
Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease.
Mannino D, Weng S, Germain G, Boudreau J, Tardif-Samson A, Forero-Schwanhaeuser S, Laliberté F, Gravelle P, Compton CH, Noorduyn SG, Paczkowski R. Mannino D, et al. Among authors: paczkowski r. Adv Ther. 2024 Dec 28. doi: 10.1007/s12325-024-03088-1. Online ahead of print. Adv Ther. 2024. PMID: 39731707
Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study.
Hoog M, Paczkowski R, Huang A, Halpern R, Buysman E, Stackland S, Zhang Y, Wangia-Dixon R. Hoog M, et al. Among authors: paczkowski r. Diabetes Ther. 2023 Nov;14(11):1947-1958. doi: 10.1007/s13300-023-01473-7. Epub 2023 Sep 23. Diabetes Ther. 2023. PMID: 37740872 Free PMC article.
30 results